Answer
Oxlumo (lumasiran sodium) is contraindicated in people with severe hypersensitivity to the active substance or any excipient listed in section 6.1.
Sources for this answer
- Oxlumo 94.5 mg/0.5 mL solution for injectionAlnylam UK Ltd · emc · SmPC §4.3 Contraindications · Version 8Document updated
Sources checked